Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions

Parish, Roy C

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions

Author(s): Parish Roy C

Issue: Nov/Dec 2009 - Geriatric Compounding
View All Articles in Issue

Page(s): 572-573

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Page 1

Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Page 2

Download in electronic PDF format for $75

Abstract: A high-performance liquid chromatographic assay method was developed to facilitate stability studies of extemporaneously compounded oral liquid formulations of ziprasidone. The method is simple and precise within the needs of the pharmaceutical profession. The throughput time is approximately 7 minutes per sample. The method is easily adaptable for individual needs.

Related Keywords: Roy C. Parish, BSP, PharmD, BCPS, ziprasidone mesylate, psychotropic agent, sedation, sedative, agitation, stability, assay

Related Categories: PEER-REVIEWED, QUALITY CONTROL, DOSAGE FORMS/DRUG CARRIERS, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Rapid, Simple Assay for Ziprasidone Mesylate in Extemporaneously Compounded Oral Solutions Parish Roy C	Nov/Dec 2009 Pg. 572-573
Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Allen Loyd V Jr	Nov/Dec 2021 Pg. 509
Chemical Stability of Progesterone in Compounded Oral Rapid-dissolving Tablets Sayre Casey L, Cox Christopher, Velazquez Gabriel, Le Minh Thi, Nguyen Amy Hong, Ramos Marjorie, Burrows Anna, Yellepeddi Venkata Kashyap	Jan/Feb 2019 Pg. 62-64
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel	Mar/Apr 2017 Pg. 160-163
Stability of Pergolide Mesylate Oral Liquid at Room Temperature Shank Brandon R, Ofner Clyde M III	May/Jun 2009 Pg. 254-258
Assaying Progesterone in Extemporaneously Prepared Suppositories Al-Achi Antoine, Webster Kathy, Greenwood Robert, Nicol Scott	Sep/Oct 1997 Pg. 339
Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J	Mar/Apr 2017 Pg. 164-170
Aminophylline 3%, Co-dergocrine Mesylate 0.05%, and Isosorbide Dinitrate 0.25% Cream for the Treatment of Orgasmic Dysfunction in Women Mason Dave	Jul/Aug 2002 Pg. 255-256
Stability of Dexmedetomidine in 0.9% Sodium Chloride in Two Types of Intravenous Infusion Bags Marquis Kathleen, Hohlfelder Benjamin, Szumita Paul M	Sep/Oct 2017 Pg. 436-439
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals Khokhlova Kateryna O, Zdoryk Oleksandr A	May/Jun 2018 Pg. 240-246
Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Allen Loyd V Jr	Sep/Oct 2018 Pg. 410
Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia	Sep/Oct 2011 Pg. 435-437
Trovafloxacin Mesylate 10-mg/mL Oral Liquid Allen Loyd V Jr	May/Jun 2007 Pg. 251
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A	Sep/Oct 2021 Pg. 431-439
Benztropine Mesylate 1-mg/mL Injection Allen Loyd V Jr	Nov/Dec 2013 Pg. 498
Phentolamine Mesylate 5-mg/mL Injection Allen Loyd V Jr	Jan/Feb 2015 Pg. 69
Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension Atkins Julia R, Lull Melinda E, Decker Andrew S, Hutchinson David J	Jul/Aug 2018 Pg. 326-328
Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G	Nov/Dec 2019 Pg. 504-510
Return to Top